CoChat

The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients

Murray, R. D., Peacey, S. R., Rahim, A., Toogood, A. A., Thorner, M. O., Shalet, S. M. · 2001 · Clinical Endocrinology
Cited by 29

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Due to persistent qualitative abnormali‐ties in GH secretion following treatment, and lack of a sensitive marker of GHD in mid‐adult life it is extremely difficult to diagnose GHD in treated acromegalic patients. The diagnosis of GHD in patients with pituitary disease relies on provocative tests of GH reserve. Arginine releases GH by reducing somatostatin inhibition of GH release, whereas GH secretagogues (GHS) affect GH release by direct stimulation of the GHS receptor, though an intact GH releasing hormone (GHRH) axis is a prerequisite. The peak GH response to insulin‐induced hypoglycaemia and arginine in acromegalic patients, in whom basal serum GH levels of less than 5 mU/l have been achieved, is greatly diminished in those treated by hypothalamo–pituitary irradiation. We aimed to study the response of successfully treated acromegalic patients to the growth hormone secretagogue hexarelin in view of its different putative mechanism of action, and in addition, to determine whether it has any value in the diagnosis of GH deficiency in this subset of patients. Nineteen acromegalic patients, in whom mean serum GH levels below 5 mU/l have been achieved through treatment, were recruited. Eight of the patients had been treated by surgery alone (Group A) and 11 had received primary or postoperative irradiation (Group B). All patients underwent 20 min blood sampling to provide a 24‐h GH profile. Serum IGF‐I was measured from a sample drawn between 0900 h and 1000 h. On a second visit arginine 20 g/m 2 was infused over 30 min, blood samples were taken before commencing the infusion and at 30‐min intervals thereafter for 180 min. At the final visit hexarelin 1·5 mcg/kg was administered as an intravenous bolus at t = 0. Blood was drawn at 15‐min intervals from − 30 to 180 min. All patients in group A showed an increment in serum GH following hexarelin (ΔGH HEX) > 20 mU/l, a normal response to arginine, and a mean 24‐h GH > 0·5 mU/l. In group B only 4/11 achieved a ΔGH HEX > 20 mU/l, 5/11 producing a response of < 2 mU/l. Four of the five patients with a ΔGH HEX < 2 mU/l were also demonstrated to have a mean 24‐h GH of < 0·5 mU/l and serum IGF‐I SDS < + 0·5. All four patients in Group B who achieved a ΔGH HEX > 20 mU/l, were observed to show an absent or minimal GH response to arginine. Despite loss of the GH response to arginine, the ΔGH HEX is retained in a proportion of those patients in whom ‘safe’ GH levels were achieved following irradiation. From the putative mechanisms of action of these provocative agents a plausible explanation would be that the GHRH axis is more resilient than endogenous somatostatin‐secreting neurones to radiation‐induced damage. Furthermore, GH secretagogues may have a role, in combination with serum IGF‐I levels, in the diagnosis of GH deficiency in treated acromegaly.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.2001.01189.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 29

Metadata

Authors
Murray, R. D., Peacey, S. R., Rahim, A., Toogood, A. A., Thorner, M. O., & Shalet, S. M.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2001-01
Volume
54
Issue
1
Pages
37-44
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2077055541
Cited by
29
References
6
FWCI
1.24
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients. https://app.cochat.ai/papers/10.1046/j.1365-2265.2001.01189.x
The paper
Murray, R. D., Peacey, S. R., Rahim, A., Toogood, A. A., Thorner, M. O., & Shalet, S. M. (2001). The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2001.01189.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.